【摘要】 目的　探讨髓内动静脉畸形的治疗方法的选择及对其疗效的评价。方法　回顾性地分析病人的临床资料， 血管影像结构及治疗方法和随访结果。结果　６４ 例病人中５７ 例接受过栓塞治疗，以微粒栓塞为主（８４％ ）， 其中１０ 例在栓塞后手术， ７ 例单纯手术。治疗后有１４ 例恢复（２１％ ）， ４７例改善（７３％ ）， ８ 例无变化（１２％ ）。５ 例在栓塞后出现并发症， 其中永久性并发症１ 例， 一过性并发症４ 例。结论　髓内ＡＶＭ 的治疗以微粒栓塞为主， 微粒栓塞可使大多数病人的神经功能障碍得以恢复和改善； 其缺点是再通率高。手术治疗可使病人获得解剖治愈， 对于能手术的病人应尽量手术。另外术前栓塞有助于手术操作更多还原

【Abstract】 Objective To discuss the therapeutic alternatives and evaluate the related clinical results. Methods Intramedullary AVMs in 64 patients were reviewed, the materials include all clinical data, angioarchitecture, therapeutic alternatives and fellow up. Results All the 64 cases accepted endovascular treatment and most of them were embolized by particulate agents. Of them 17 cases were surgically excised after embolization. As follow up, 14/64 patients (21 72%) are neurologically normal and 47/64(77 44%) have improved their clinical conditions and neurological deficits. 8/64(12 64) remained clinically stable. 4/64(6 25) presented transient worsening of their clinical condition after embolization, permanent morbidity occurred in one patient(1 56%). Conclusion Particulate embolization is currently playing an important role in intramedullary AVMs, but its recanalization rate is high(89%). Despite of recanalization their clinical outcome were satisfactory.更多还原